Clinical trial
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
NCT00164073 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection
- Lead sponsor
- Bayside Health
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 29, 2004
- Completion date
- February 28, 2007
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.